The single Phase 2 human-efficacy trial of ipamorelin in any indication (Beck 2014 NCT00672074 postoperative ileus, n = 114 to 117 mITT) was conducted with ipamorelin monotherapy and missed its pre-specified primary endpoint at p = 0.15 [8]
PMCID: PMC3270907
Wang S, Zhu H, Pan L, Zhang M, Wan X, Xu H, et al
Donate Today You can help support and enhance services, and in turn, help patients and their families who benefit from care received at Aultman.
10.1161/CIRCULATIONAHA.118.035889 156 YuW.LuoJ.ZhangA.ZhengY.ZhuL.GuY.et al (2020)
Harasta AE, Power JM, von Jonquieres G, Karl T, Drucker DJ, Housley GD et al